Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular CarcinomaLaia Bassaganyas, Roser Pinyol, Roger Esteban-Fabró, et al.
Journal of Medical Virology|June 1, 2010
Immunovirological correlates in human rabies treated with therapeutic comaM Hunter, N Johnson, S Hedderwick, et al.
Viruses|July 22, 2010
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WISwati Kumar, Michael J Chusid, Rodney E Willoughby, et al.
Clinical Genetics|April 15, 2014
Phenotypic heterogeneity and mutational spectrum in a cohort of 45 Italian males subjects with X-linked ectodermal dysplasiaL Guazzarotti, G Tadini, G E Mancini, et al.
British Journal of Cancer|November 11, 2017
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?Jane Margetts, Laura F Ogle, Stephen L Chan, et al.
Human Molecular Genetics|June 5, 2014
Enrichment of pathogenic alleles in the brittle cornea gene, ZNF469, in keratoconusJudith Lechner, Louise F Porter, Aine Rice, et al.
Ophthalmology|January 21, 2016
A COL17A1 Splice-Altering Mutation Is Prevalent in Inherited Recurrent Corneal ErosionsVerity F Oliver, Katherine A van Bysterveldt, Murray Cadzow, et al.
Investigative Ophthalmology & Visual Science|April 20, 2013
Mutational spectrum of the ZEB1 gene in corneal dystrophies supports a genotype-phenotype correlationJudith Lechner, Durga P Dash, Dorota Muszynska, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkersAndrew McLain, Suzanne R Saffie-Siebert, Nadia Sukusu Nielsen, et al.
Scientific Reports|February 4, 2018
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linkingAnna H Turaj, Kerry L Cox, Christine A Penfold, et al.
Pageof 21